On 21 MAY Sutor Technology Group Ltd. (NASDAQ:SUTR) a leading China-based non-state owned manufacturer and distributor of high-end fine finished steel products used by a variety of downstream applications, announced it will present at the third Annual Marcum MicroCap Conference on Thursday, May 29, 2014 at the Grand Hyatt Hotel in New York City. The Company is scheduled to present at 11:00am. Sutor Technology Group Ltd. (NASDAQ:SUTR) net profit margin is 3.60% and weekly performance is -14.73%. On last trading day company shares ended up $0.938. Analysts mean target price for the company is $2.50. Sutor Technology Group Ltd. (NASDAQ:SUTR) distance from 50-day simple moving average (SMA50) is -44.51%.
On 20 MAY TrovaGene Inc (NASDAQ:TROV) a developer of cell-free molecular diagnostics, announced that data published from ongoing clinical validation studies demonstrate that the company’s precision cancer monitoring technology is suitable to non-invasively determine oncogene mutation status in patients with malignant disease. TrovaGene Inc (NASDAQ:TROV) shares advanced 0.57% in last trading session and ended the day on $3.55. TROV return on assets is -67.70%. TrovaGene Inc (NASDAQ:TROV) quarterly performance is -45.13%.
On 7 MAY AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) reported its first quarter 2014. Q1 2014 ended with $88.3 million in cash, cash equivalents and marketable securities. Total collaboration revenue was approximately $15.3 million compared with $0.3 million for Q1 2013. The increase was primarily due to an additional one-time recognition of $14.1 million of previously deferred revenue as a result of the modification of the company’s arrangement with Biogen Idec.AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) was closed at $1.07, while trading in range of $1.05 – $1.10. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) year to date (YTD) performance is -41.53%.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) reported ($0.17) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.23) by $0.06. Analysts expect that ITI will post $-1.19 EPS for the current fiscal year. Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) ended the last trading day at $15.25. Company weekly volatility is calculated as 4.85%. Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) showed a negative weekly performance of -3.54%.
On 16 MAY TrueCar, Inc. (NASDAQ:TRUE) guaranteed savings certificates and seamlessly complete the car purchase. TrueCar, Inc. (NASDAQ:TRUE)’s transparent upfront pricing information and guaranteed savings certificate make the car buying process simple so buyers never overpay. TrueCar, Inc. (NASDAQ:TRUE) weekly performance is -8.35%. On last trading day company shares ended up $9.22. TrueCar, Inc. (NASDAQ:TRUE) distance from 50-day simple moving average (SMA50) is -4.73%.